FMP
Sep 13, 2025 8:00 PM - Tony Dante(Last modified: Sep 15, 2025 3:36 PM)
Image credit: Google Images
DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) is a prominent player in the digital gaming industry, known for its engaging social casino games. The company operates in a competitive market alongside peers like Bragg Gaming Group Inc., Integral Ad Science Holding Corp., Gambling.com Group Limited, and European Wax Center, Inc. Analyzing the Return on Invested Capital (ROIC) versus the Weighted Average Cost of Capital (WACC) provides insight into how effectively these companies utilize their capital.
DoubleDown Interactive boasts a ROIC of 10.23%, surpassing its WACC of 7.69%. This results in a ROIC to WACC ratio of 1.33, indicating that the company generates returns well above its cost of capital. This efficiency in capital utilization is a positive indicator for investors, suggesting that DDI is effectively managing its resources to create value.
In contrast, Bragg Gaming Group Inc. struggles with a negative ROIC of -5.20%, which is below its WACC of 6.64%. This results in a ROIC to WACC ratio of -0.78, highlighting inefficiencies in generating returns on its invested capital. Such a disparity suggests that Bragg Gaming is not effectively using its capital to generate profits.
Integral Ad Science Holding Corp. also faces challenges, with a ROIC of 5.77% that falls short of its WACC of 10.85%. The ROIC to WACC ratio of 0.53 indicates that the company is not covering its cost of capital, pointing to potential inefficiencies in capital management. This could be a concern for investors looking for companies with strong capital efficiency.
Gambling.com Group Limited and European Wax Center, Inc. both have ROICs below their respective WACCs, with ratios of 0.66 and 0.88. While European Wax Center is closer to covering its cost of capital, both companies show inefficiencies in capital utilization. This comparison underscores DoubleDown Interactive's superior performance in generating returns above its cost of capital, making it a potentially more attractive investment opportunity.
Alkermes plc, listed on Nasdaq as ALKS, is a global biopharmaceutical company headquartered in Ireland. It focuses on de...
Nektar Therapeutics (NASDAQ:NKTR) is a biopharmaceutical company that focuses on developing innovative medicines in area...